Spain· ES:10645002
BRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION
A vernakalant product containing vernakalant, registered in Spain by Advanz Pharma Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Vernakalant is registered in 12 of 19 countries.
Countries holding a registration under ATC C01BG11 (vernakalant), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 7 of them publish a price we can compare per daily dose
Vernakalant · ATC C01BG11
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- vernakalant
- Manufacturer
- Advanz Pharma Limited
- Country
- Spain (ES)
- ATC code
- C01BG11
- ATC class
- Vernakalant
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vernakalant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRINAVESSADVANZ PHARMA Limited, Dublin
- BelgiumBrinavess 20 mg/mlAdvanz Pharma
- FinlandBRINAVESSAdvanz Pharma Limited
- United KingdomBrinavess 500mg/25ml concentrate for solution for infusion vialsAdvanz Pharma
- IrelandBRINAVESS 20 mg/ml concentrate for solution for infusionCorrevio
- IcelandBrinavessADVANZ PHARMA Limited
- NetherlandsBrinavess 20 mg / ml, concentraat voor oplossing voor infusieAdvanz Pharma Limited
- PolandBrinavessCorrevio
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brinavess
- Liechtenstein · Brinavess
- Norway · Brinavess
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b8064b9-923b-4a73-99e1-cebe26811fef GET /v1/drugs/6b8064b9-923b-4a73-99e1-cebe26811fef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1287439200000}",
"nregistro": "10645002",
"substance": "vernakalant"
}See everything about vernakalant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.